ClotCare: Blood Clots, Stroke, Heart Attack
Monday, May 27, 2024
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

Warfarin Pharmacogenetics Survey

Marie B. Walker
December, 2008

In collaboration with the Anticoagulation Forum, the University of California, San Francisco Pharmacy School is conducting a survey, "Anticoagulation Providers and Warfarin Pharmacogenetics." Anticoagulation therapy providers in North America are asked to participate. The topic of this survey concerns the clinical application of warfarin pharmacogenetics. As you may know, the FDA recommends lowering the starting dose of warfarin in patients with certain genetic variants. See for more on this issue. The objective of the study is to identify those factors that may influence the clinical application of this new recommendation because it requires the application of new knowledge and technology.

This survey study has been approved by Committee on Human Research at the University of California, San Francisco. Questions may be directed to Jaekyu Shin, Pharm.D, BCPS at 415-514-2747 (office, from 8 AM to 5 PM Pacific Standard Time) or email me at Data collected from this study will be used only for research purposes.

The survey questionnaire consists of 25 questions. It is estimated to take about 10-15 minutes to participate in the study. The survey questionnaire can be found at

The conclusions of the survey and the answer keys to the knowledge questions will be shared after completion of the study. Please indicate your desire to receive this information by providing your name and address at the end of the online survey. Your identifiers will not be linked to the survey questionnaire. Those conducting the survey anticipate that it will be completed by June, 2009.

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to
Monday, May 27, 2024